{"entity":{"type":"insider","cik":"0001461753","url":"/insider/0001461753","json_url":"/insider/0001461753.json","name":"Marguglio David J.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":34,"n_filings":33,"first":"2014-06-04","last":"2022-03-22","span_basis":"filed_date"},"name_variants":[{"name":"Marguglio David J.","source":"filing","n_filings":33,"first_seen":"2014-06-04","last_seen":"2022-03-22"}],"transactions":[{"id":6867203,"accession":"0001387131-22-003862","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-22-003862","line_url":"/filing/0001387131-22-003862#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (SVP and Chief Business Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11859.0,"shares_display":"11,859","price_per_share":0.6001,"price_display":"0.60","price_state":"stated","total_value":7116.5859,"total_display":"7,116.59","total_whole":"7,117","shares_owned_after":233906.0,"shares_owned_after_display":"233,906","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-18","filed_date":"2022-03-22","scope":"insider"},{"id":4642050,"accession":"0001387131-21-011776","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-21-011776","line_url":"/filing/0001387131-21-011776#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (SVP and Chief Business Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50757.0,"shares_display":"50,757","price_per_share":0.785,"price_display":"0.78","price_state":"stated","total_value":39844.245,"total_display":"39,844.24","total_whole":"39,844","shares_owned_after":258765.0,"shares_owned_after_display":"258,765","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-01","filed_date":"2021-12-03","scope":"insider"},{"id":2272677,"accession":"0001593968-20-002246","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-20-002246","line_url":"/filing/0001593968-20-002246#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (SVP and Chief Business Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":0.4,"price_display":"0.40","price_state":"stated","total_value":14000.0,"total_display":"14,000.00","total_whole":"14,000","shares_owned_after":287264.0,"shares_owned_after_display":"287,264","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-20","filed_date":"2020-11-24","scope":"insider"},{"id":2439295,"accession":"0001593968-20-002228","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-20-002228","line_url":"/filing/0001593968-20-002228#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (SVP and Chief Business Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8532.0,"shares_display":"8,532","price_per_share":0.4061,"price_display":"0.41","price_state":"stated","total_value":3464.8452,"total_display":"3,464.85","total_whole":"3,465","shares_owned_after":322264.0,"shares_owned_after_display":"322,264","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-18","filed_date":"2020-11-20","scope":"insider"},{"id":2493479,"accession":"0001593968-20-001949","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-20-001949","line_url":"/filing/0001593968-20-001949#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (SVP and Chief Business Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":0.8,"price_display":"0.80","price_state":"stated","total_value":16000.0,"total_display":"16,000.00","total_whole":"16,000","shares_owned_after":308539.0,"shares_owned_after_display":"308,539","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-29","filed_date":"2020-10-01","scope":"insider"},{"id":2716141,"accession":"0001593968-20-001774","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-20-001774","line_url":"/filing/0001593968-20-001774#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (SVP and Chief Business Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8749.0,"shares_display":"8,749","price_per_share":0.8741,"price_display":"0.87","price_state":"stated","total_value":7647.5009,"total_display":"7,647.50","total_whole":"7,648","shares_owned_after":328539.0,"shares_owned_after_display":"328,539","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-18","filed_date":"2020-08-20","scope":"insider"},{"id":2157462,"accession":"0001593968-20-001224","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-20-001224","line_url":"/filing/0001593968-20-001224#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (SVP and Chief Business Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7734.0,"shares_display":"7,734","price_per_share":0.5601,"price_display":"0.56","price_state":"stated","total_value":4331.8134,"total_display":"4,331.81","total_whole":"4,332","shares_owned_after":337288.0,"shares_owned_after_display":"337,288","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-18","filed_date":"2020-05-20","scope":"insider"},{"id":3107718,"accession":"0001593968-20-000863","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-20-000863","line_url":"/filing/0001593968-20-000863#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (SVP and Chief Business Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10337.0,"shares_display":"10,337","price_per_share":0.3366,"price_display":"0.34","price_state":"stated","total_value":3479.4342,"total_display":"3,479.43","total_whole":"3,479","shares_owned_after":325022.0,"shares_owned_after_display":"325,022","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-18","filed_date":"2020-03-19","scope":"insider"},{"id":2319273,"accession":"0001593968-20-000523","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-20-000523","line_url":"/filing/0001593968-20-000523#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (SVP and Chief Business Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9948.0,"shares_display":"9,948","price_per_share":0.6035,"price_display":"0.60","price_state":"stated","total_value":6003.618,"total_display":"6,003.62","total_whole":"6,004","shares_owned_after":335359.0,"shares_owned_after_display":"335,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-24","filed_date":"2020-02-26","scope":"insider"},{"id":8140430,"accession":"0001593968-19-002186","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-19-002186","line_url":"/filing/0001593968-19-002186#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (SVP and Chief Business Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8283.0,"shares_display":"8,283","price_per_share":0.8689,"price_display":"0.87","price_state":"stated","total_value":7197.0987,"total_display":"7,197.10","total_whole":"7,197","shares_owned_after":365307.0,"shares_owned_after_display":"365,307","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-18","filed_date":"2019-11-20","scope":"insider"},{"id":7826410,"accession":"0001593968-19-001777","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-19-001777","line_url":"/filing/0001593968-19-001777#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (SVP and Chief Business Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8109.0,"shares_display":"8,109","price_per_share":1.0955,"price_display":"1.10","price_state":"stated","total_value":8883.4095,"total_display":"8,883.41","total_whole":"8,883","shares_owned_after":373590.0,"shares_owned_after_display":"373,590","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-19","filed_date":"2019-08-21","scope":"insider"},{"id":8354150,"accession":"0001593968-19-001169","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-19-001169","line_url":"/filing/0001593968-19-001169#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (SVP and Chief Business Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8735.0,"shares_display":"8,735","price_per_share":1.7703,"price_display":"1.77","price_state":"stated","total_value":15463.5705,"total_display":"15,463.57","total_whole":"15,464","shares_owned_after":381699.0,"shares_owned_after_display":"381,699","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-20","filed_date":"2019-05-22","scope":"insider"},{"id":8140335,"accession":"0001593968-19-000833","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-19-000833","line_url":"/filing/0001593968-19-000833#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (SVP and Chief Business Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10579.0,"shares_display":"10,579","price_per_share":2.2788,"price_display":"2.28","price_state":"stated","total_value":24107.4252,"total_display":"24,107.43","total_whole":"24,107","shares_owned_after":390434.0,"shares_owned_after_display":"390,434","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-20","filed_date":"2019-03-22","scope":"insider"},{"id":3230254,"accession":"0001387131-16-005782","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-16-005782","line_url":"/filing/0001387131-16-005782#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (SR. VP of Corporate Devel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SR. VP of Corporate Devel.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":9.0015,"price_display":"9.00","price_state":"stated","total_value":6301.05,"total_display":"6,301.05","total_whole":"6,301","shares_owned_after":101527.0,"shares_owned_after_display":"101,527","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-02","filed_date":"2016-06-06","scope":"insider"},{"id":2529116,"accession":"0001387131-16-005612","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-16-005612","line_url":"/filing/0001387131-16-005612#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (SR VP OF CORPORATE DEVELOPMENT)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SR VP OF CORPORATE DEVELOPMENT","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":8.0848,"price_display":"8.08","price_state":"stated","total_value":32339.2,"total_display":"32,339.20","total_whole":"32,339","shares_owned_after":102227.0,"shares_owned_after_display":"102,227","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-16","filed_date":"2016-05-18","scope":"insider"},{"id":9285874,"accession":"0001387131-16-005609","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-16-005609","line_url":"/filing/0001387131-16-005609#line-1","is_derivative":false,"issuer_cik":"0001461753","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0001461753","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (SR VP OF CORPORATE DEVELOPMENT)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SR VP OF CORPORATE DEVELOPMENT","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":60000.0,"total_display":"60,000.00","total_whole":"60,000","shares_owned_after":106227.0,"shares_owned_after_display":"106,227","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-09","filed_date":"2016-05-18","scope":"insider"},{"id":3267411,"accession":"0001387131-16-005405","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-16-005405","line_url":"/filing/0001387131-16-005405#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (SR VP of Corporate Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SR VP of Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4860.0,"shares_display":"4,860","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":48600.0,"total_display":"48,600.00","total_whole":"48,600","shares_owned_after":106227.0,"shares_owned_after_display":"106,227","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-09","filed_date":"2016-05-11","scope":"insider"},{"id":2940442,"accession":"0001387131-16-005305","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-16-005305","line_url":"/filing/0001387131-16-005305#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (SR VP of Corporate Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SR VP of Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4860.0,"shares_display":"4,860","price_per_share":9.1722,"price_display":"9.17","price_state":"stated","total_value":44576.892,"total_display":"44,576.89","total_whole":"44,577","shares_owned_after":112227.0,"shares_owned_after_display":"112,227","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-04","filed_date":"2016-05-06","scope":"insider"},{"id":2806578,"accession":"0001387131-16-005280","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-16-005280","line_url":"/filing/0001387131-16-005280#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (SR VP of Corporate Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SR VP of Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1140.0,"shares_display":"1,140","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":10260.0,"total_display":"10,260.00","total_whole":"10,260","shares_owned_after":117087.0,"shares_owned_after_display":"117,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-03","filed_date":"2016-05-05","scope":"insider"},{"id":2613113,"accession":"0001387131-16-005003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-16-005003","line_url":"/filing/0001387131-16-005003#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (SR VP of Corporate Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SR VP of Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":7.518,"price_display":"7.52","price_state":"stated","total_value":90216.0,"total_display":"90,216.00","total_whole":"90,216","shares_owned_after":118227.0,"shares_owned_after_display":"118,227","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-14","filed_date":"2016-04-18","scope":"insider"},{"id":8938413,"accession":"0001209191-15-035602","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-035602","line_url":"/filing/0001209191-15-035602#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (Sr VP of Business Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP of Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":1000.0,"total_display":"1,000.00","total_whole":"1,000","shares_owned_after":140323.0,"shares_owned_after_display":"140,323","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-20","filed_date":"2015-04-22","scope":"insider"},{"id":8793056,"accession":"0001209191-15-035178","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-035178","line_url":"/filing/0001209191-15-035178#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (Sr VP of Business Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP of Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":5.01,"price_display":"5.01","price_state":"stated","total_value":501.0,"total_display":"501.00","total_whole":"501","shares_owned_after":140523.0,"shares_owned_after_display":"140,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-17","filed_date":"2015-04-20","scope":"insider"},{"id":8692045,"accession":"0001209191-15-035091","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-035091","line_url":"/filing/0001209191-15-035091#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (Sr VP of Business Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP of Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":5.0009,"price_display":"5.00","price_state":"stated","total_value":3500.63,"total_display":"3,500.63","total_whole":"3,501","shares_owned_after":140623.0,"shares_owned_after_display":"140,623","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-16","filed_date":"2015-04-17","scope":"insider"},{"id":8126998,"accession":"0001209191-15-034398","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-034398","line_url":"/filing/0001209191-15-034398#line-2","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (Sr VP of Business Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP of Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":500.0,"total_display":"500.00","total_whole":"500","shares_owned_after":141323.0,"shares_owned_after_display":"141,323","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-14","filed_date":"2015-04-15","scope":"insider"},{"id":8126993,"accession":"0001209191-15-034398","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-034398","line_url":"/filing/0001209191-15-034398#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (Sr VP of Business Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP of Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2100.0,"shares_display":"2,100","price_per_share":5.0115,"price_display":"5.01","price_state":"stated","total_value":10524.15,"total_display":"10,524.15","total_whole":"10,524","shares_owned_after":141423.0,"shares_owned_after_display":"141,423","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-13","filed_date":"2015-04-15","scope":"insider"},{"id":8293118,"accession":"0001209191-15-022766","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-022766","line_url":"/filing/0001209191-15-022766#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (Sr VP of Business Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP of Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11800.0,"shares_display":"11,800","price_per_share":7.09,"price_display":"7.09","price_state":"stated","total_value":83662.0,"total_display":"83,662.00","total_whole":"83,662","shares_owned_after":143523.0,"shares_owned_after_display":"143,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-04","filed_date":"2015-03-05","scope":"insider"},{"id":8574422,"accession":"0001209191-15-021899","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-021899","line_url":"/filing/0001209191-15-021899#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (Sr VP of Business Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP of Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":6.45,"price_display":"6.45","price_state":"stated","total_value":45150.0,"total_display":"45,150.00","total_whole":"45,150","shares_owned_after":155323.0,"shares_owned_after_display":"155,323","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-02","filed_date":"2015-03-03","scope":"insider"},{"id":8219603,"accession":"0001387131-15-000051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-15-000051","line_url":"/filing/0001387131-15-000051#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (Sr VP of Business Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP of Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":1400.0,"total_display":"1,400.00","total_whole":"1,400","shares_owned_after":164273.0,"shares_owned_after_display":"164,273","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-08","filed_date":"2015-01-09","scope":"insider"},{"id":8922769,"accession":"0001387131-15-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-15-000013","line_url":"/filing/0001387131-15-000013#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (Senior VP of Bus. Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP of Bus. Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":6.18,"price_display":"6.18","price_state":"stated","total_value":43260.0,"total_display":"43,260.00","total_whole":"43,260","shares_owned_after":164473.0,"shares_owned_after_display":"164,473","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-05","filed_date":"2015-01-06","scope":"insider"},{"id":6800325,"accession":"0001387131-14-004186","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-14-004186","line_url":"/filing/0001387131-14-004186#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (Sr VP of Business Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP of Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12228.0,"shares_display":"12,228","price_per_share":6.09,"price_display":"6.09","price_state":"stated","total_value":74468.52,"total_display":"74,468.52","total_whole":"74,469","shares_owned_after":171473.0,"shares_owned_after_display":"171,473","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-30","filed_date":"2014-12-31","scope":"insider"},{"id":6800323,"accession":"0001387131-14-004184","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-14-004184","line_url":"/filing/0001387131-14-004184#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (Senior VP of Bus. Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP of Bus. Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":772.0,"shares_display":"772","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":4632.0,"total_display":"4,632.00","total_whole":"4,632","shares_owned_after":183701.0,"shares_owned_after_display":"183,701","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-29","filed_date":"2014-12-31","scope":"insider"},{"id":6466043,"accession":"0001387131-14-004062","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-14-004062","line_url":"/filing/0001387131-14-004062#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (Sr VP of Business Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP of Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":5.1847,"price_display":"5.18","price_state":"stated","total_value":20738.8,"total_display":"20,738.80","total_whole":"20,739","shares_owned_after":184473.0,"shares_owned_after_display":"184,473","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-12","filed_date":"2014-12-15","scope":"insider"},{"id":7084610,"accession":"0001387131-14-003211","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-14-003211","line_url":"/filing/0001387131-14-003211#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (Sr VP of Business Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP of Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":5.059,"price_display":"5.06","price_state":"stated","total_value":40472.0,"total_display":"40,472.00","total_whole":"40,472","shares_owned_after":188473.0,"shares_owned_after_display":"188,473","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-02","filed_date":"2014-09-04","scope":"insider"},{"id":6712277,"accession":"0001387131-14-002134","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-14-002134","line_url":"/filing/0001387131-14-002134#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461753","owner_name":"Marguglio David J.","owner_display_name":"Marguglio David J.","owner_url":"/insider/0001461753","role":"Director, Officer (Sr VP of Business Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP of Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":5.564,"price_display":"5.56","price_state":"stated","total_value":22256.0,"total_display":"22,256.00","total_whole":"22,256","shares_owned_after":202354.0,"shares_owned_after_display":"202,354","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-02","filed_date":"2014-06-04","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":34,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":34,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":34},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000887247","name":"Adamis Pharmaceuticals Corp","url":"/issuer/0000887247","role":"Director, Officer (SVP and Chief Business Officer)","n_filings":33,"first_seen":"2014-06-04","last_seen":"2022-03-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001461753","retrieved_at":"2026-08-24T03:09:53+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}